Redeye embraces the not-so-unanticipated SEK50m directed share issue, giving the company additional buffer for its growth activities. The injection should allow Integrum to act more freely on sales and marketing activities, and the coming few quarters’ sales progression could prove pivotal for the case.
LÄS MER